Systematic review + Bayesian meta-analysis: Biosimilars of adalimumab, infliximab, and etanercept were associated with clinically equivalent treatment effects compared to their reference biologics for rheumatoid arthritis. https://t.co/aGANXz2ya0
Systematic review + Bayesian meta-analysis: Biosimilars of adalimumab, infliximab, and etanercept were associated with clinically equivalent treatment effects compared to their reference biologics for rheumatoid arthritis. https://t.co/aGANXz2ya0